natalizumab
Class Immunosuppressive agent, immunomodulator Natalizumab Commonly Prescribed for (FDA approved in bold) Reducing neurologic disability or relapses in patients with progressive relapsing, or worsening relapsing-remitting multiple sclerosis. (MS) Crohn’s disease…